Discover

HALO
Halozyme Therapeutics, Inc.
79.11
1 x 79.08
1 x 79.11
bid
ask
+
0.51
0.64%
12:08 PM
timesize
Ytd17.54%
1y37.48%
78.22
day range
79.31
56.05
52 week range
82.26
Open79.23Prev Close78.60Low78.22High79.31Mkt Cap9.32B
Vol422.03KAvg Vol1.81MEPS4.62P/E17.01Forward P/E10.54
Beta0.84Short Ratio6.94Inst. Own108.50%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0450-d Avg72.10200-d Avg69.251yr Est83.90

HALO News

Halozyme's Partnerships, Earnings Growth See Shares Near All-Time Highs
fxempire.com
Halozyme's Partnerships, Earnings Growth See Shares Near All-Time Highs

Halozyme Therapeutics, Inc. (HALO) shares gain 539% since first Big Money outlier inflow signal in M

HALO Inks Deal With INCY to Support Cancer Therapy Development
zacks.com
HALO Inks Deal With INCY to Support Cancer Therapy Development

Halozyme grants ENHANZE rights to Incyte for developing subcutaneous cancer therapy formulations, ai

benzinga.com
Halozyme Therapeutics Signs Agreement With Incyte To Mull Additional Subcutaneous Formulations Of IN

Halozyme Therapeutics, Inc. (NASDAQ:HALO) ("Halozyme" or the "Company") today announ

Halozyme Announces Global Collaboration and License Agreement with Incyte to Support the Development of Subcutaneous Formulations of INCA033989 Using its ENHANZE® Technology
prnewswire.com
Halozyme Announces Global Collaboration and License Agreement with Incyte to Support the Development

Agreement provides Incyte the rights to develop and commercialize ENHANZE® with its mutCALR developm

Fifth Third Bancorp Grows Position in Halozyme Therapeutics, Inc. $HALO
defenseworld.net
Fifth Third Bancorp Grows Position in Halozyme Therapeutics, Inc. $HALO

Fifth Third Bancorp increased its holdings in Halozyme Therapeutics, Inc. (NASDAQ: HALO) by 4,206.4%

Inflation Cools But US-Iran Tensions Rise: 4 Value Stocks to Buy Now
zacks.com
Inflation Cools But US-Iran Tensions Rise: 4 Value Stocks to Buy Now

ARCO, HALO, TX and ARRY screen as high-earnings-yield value picks as the Middle-East conflict sharpe

Time for HALO Sectors & ETFs?
zacks.com
Time for HALO Sectors & ETFs?

HALO stocks are gaining favor as investors rotate toward tangible assets and AI-resistant businesses

Time to Buy Wide Moat & HALO ETFs?
zacks.com
Time to Buy Wide Moat & HALO ETFs?

Wall Street is caught in the midst of shifting geopolitical stances of the United States and Iran, c

Halozyme Appoints David Ramsay as President Drug Delivery
prnewswire.com
Halozyme Appoints David Ramsay as President Drug Delivery

SAN DIEGO, June 30, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme" or t

Halozyme Confirms It Projects Zero to Minimal Impact to Royalty Revenue Through At Least 2035 Based on Newly Released Draft Medicare Drug Price Negotiation Program Proposed Rule for IPAY 2029
prnewswire.com
Halozyme Confirms It Projects Zero to Minimal Impact to Royalty Revenue Through At Least 2035 Based

SAN DIEGO, June 15, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme" or t

Halozyme Therapeutics (HALO) Up 0.8% Since Last Earnings Report: Can It Continue?
zacks.com
Halozyme Therapeutics (HALO) Up 0.8% Since Last Earnings Report: Can It Continue?

Halozyme Therapeutics (HALO) reported earnings 30 days ago. What's next for the stock?

Anti-AI Investing: The HALO Moat Goes Off The Rails
seekingalpha.com
Anti-AI Investing: The HALO Moat Goes Off The Rails

North American railroads like UNP, NSC, CSX, CNI, and CP exhibit HALO traits: irreplaceable heavy as

Sky Harbour: The Ultimate HALO Investment Taking Flight
seekingalpha.com
Sky Harbour: The Ultimate HALO Investment Taking Flight

Sky Harbour is building a national network of private aviation campuses on some of America's most ir

Anti-AI Investing: The HALO Moat
seekingalpha.com
Anti-AI Investing: The HALO Moat

I focus on HALO investing: Heavy Assets, Low Obsolescence - owning irreplaceable physical assets wit

Implied Volatility Surging for Halozyme Therapeutics Stock Options
zacks.com
Implied Volatility Surging for Halozyme Therapeutics Stock Options

Investors need to pay close attention to HALO stock based on the movements in the options market lat

Halozyme Therapeutics: Royalty King
seekingalpha.com
Halozyme Therapeutics: Royalty King

Halozyme Therapeutics is delivering strong shareholder value, driven by robust royalty growth and di

Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO™ Clarity and Nexalin NeuroCare™ Ahead of Planned FDA Pivotal Trial
globenewswire.com
Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO™ Clarity and Nexalin NeuroCare™ A

Acquisition gives Nexalin control of AI-integrated remote patient-monitoring, clinical data-capture

One of the market's hottest stock themes is buying everything AI can't replace
cnbc.com
One of the market's hottest stock themes is buying everything AI can't replace

Josh Brown, co-founder and CEO of Ritholtz Wealth Management, coined the term HALO as a way to ident

Roundhill launches "HALO" ETF
youtube.com
Roundhill launches "HALO" ETF

Dave Mazza, CEO of Roundhill Investments, joins CNBC's "Halftime Report" to highlight the launch of

Halozyme's Q1 Earnings & Revenues Beat Estimates, Stock Up
zacks.com
Halozyme's Q1 Earnings & Revenues Beat Estimates, Stock Up

HALO beats Q1 earnings estimates as royalty revenues from partner drugs and strong product sales lif

Halozyme Therapeutics, Inc. (HALO) Q1 2026 Earnings Call Transcript
seekingalpha.com
Halozyme Therapeutics, Inc. (HALO) Q1 2026 Earnings Call Transcript

Halozyme Therapeutics, Inc. (HALO) Q1 2026 Earnings Call Transcript

Earnings Scheduled For May 11, 2026
benzinga.com
Earnings Scheduled For May 11, 2026

benzinga.com
Halozyme Therapeutics Signs License Agreement With GSK For ENHANZE Drug Delivery Technology To Devel

Halozyme Therapeutics, Inc. (NASDAQ:HALO) ("Halozyme" or the "Company") today announ

Tech Stocks Rebound, Crude Rallies Above $64 On Iran Tensions: What's Moving Markets Wednesday?
benzinga.com
Tech Stocks Rebound, Crude Rallies Above $64 On Iran Tensions: What's Moving Markets Wednesday?

Tech stocks recovered on Wednesday, led by a rally in battered software names, as the Nasdaq 100 jum

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session

Earnings Scheduled For February 17, 2026
benzinga.com
Earnings Scheduled For February 17, 2026

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

Earnings Scheduled For November 3, 2025
benzinga.com
Earnings Scheduled For November 3, 2025

benzinga.com
Earnings Scheduled For August 5, 2025

benzinga.com
Earnings Scheduled For May 6, 2025

benzinga.com
Earnings Scheduled For February 18, 2025

benzinga.com
Earnings Scheduled For November 6, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn

benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023

benzinga.com
Earnings Scheduled For May 9, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn

benzinga.com
Earnings Scheduled For February 21, 2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is likely to report earnings for its f

benzinga.com
Stocks That Hit 52-Week Highs On Thursday

Stocks That Hit 52-Week Highs On Thursday

benzinga.com
Stocks That Hit 52-Week Highs On Wednesday

Stocks That Hit 52-Week Highs On Wednesday

benzinga.com
Stocks Which Set New 52-Week Low Yesterday, October 23rd

Stocks Which Set New 52-Week Low Yesterday, October 23rd